Entasis Therapeutics Holdings Inc (ETTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Manoussos Perros
Employees:
33
35 GATEHOUSE DRIVE, WALTHAM, MA 02451
(781) 810-0120

Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Entasis Therapeutics Holdings Inc. was incorporated under the laws of the State of Delaware in March 2018. With principal executive offices located at 35 Gatehouse Drive, Waltham, Massachusetts 02451 and telephone number is (781) 810-0120. Our website address is www.entasistx.com.

Data derived from most recent annual or quarterly report
Market Cap 75.267 Million Shares Outstanding47.638 Million Avg 30-day Volume 79.228 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.26
Price to Revenue0.0 Debt to Equity0.0 EBITDA-45.862 Million
Price to Book Value1.8041 Operating Margin0.0 Enterprise Value34.907 Million
Current Ratio6.417 EPS Growth0.645 Quick Ratio5.594
1 Yr BETA 0.8194 52-week High/Low 3.88 / 1.54 Profit Margin0.0
Operating Cash Flow Growth12.062 Altman Z-Score-1.465 Free Cash Flow to Firm -35.136 Million
View SEC Filings from ETTX instead.

View recent insider trading info

Funds Holding ETTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ETTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HASTINGS DAVID C

  • Director
49,500 2022-01-18 2

MEEK DAVID D.

  • Director
49,500 2022-01-18 2

KEILEY ELIZABETH M GENERAL COUNSEL

  • Officer
167,572 2022-01-18 3

GUTCH MICHAEL SEE REMARKS

  • Officer
167,572 2022-01-18 3

MAYER HOWARD

  • Director
49,500 2022-01-18 2

TOMMASI RUBEN CHIEF SCIENTIFIC OFFICER

  • Officer
189,596 2022-01-18 3

PERROS MANOUSSOS SEE REMARKS

  • Officer
534,572 2022-01-18 3

BEHANNA HEATHER

  • Director
49,500 2022-01-18 2

MUELLER JOHN PATRICK CHIEF DEVELOPMENT OFFICER

  • Officer
167,092 2022-01-18 3

ALTARAC DAVID CHIEF MEDICAL OFFICER

  • Officer
167,572 2022-01-18 3

RONSHEIM MATTHEW SEE REMARKS

  • Officer
167,572 2022-01-18 3

TRIOLA ANNA DIAZ CHIEF COMMERCIAL OFFICER

  • Officer
125,000 2022-01-18 3

INNOVIVA, INC.

INNOVIVA STRATEGIC OPPORTUNITIES LLC

  • 10% Owner
57,345,794 2021-06-11 2

INNOVIVA, INC.

  • 10% Owner
37,345,794 2020-09-01 2

KIMBLE ERIC WILSON CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-23 0

FRAZIER LIFE SCIENCES VIII, L.P.

TOPPER JAMES N

FHM LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

HERON PATRICK J

  • 10% Owner
No longer subject to file 2020-01-09 0

GALAKATOS NICHOLAS

  • Director
0 2019-06-19 0

NORDEN GREGORY

  • Director
0 2019-06-19 0

PRESTON HEATHER

  • Director
0 2019-06-19 0

TOPPER JAMES N

  • Director
  • 10% Owner
0 2019-01-18 0

ISAACS ROBIN CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-18 0

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE CLARUS III L.L.C.

BLACKSTONE HOLDINGS I/II GP INC

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
1,623,405 2019-01-04 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
2,514,881 2018-09-28 0

ASTRAZENECA PLC

ASTRAZENECA AB

  • 10% Owner
2,164,855 2018-09-28 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

MEHRA ANAND

POWELL MICHAEL

  • 10% Owner
1,539,445 2018-09-28 0

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

CLARUS VENTURES III, LLC

SIMON NICHOLAS

LIPTAK ROBERT

HENNER DENNIS

REQUADT SCOTT

WHEELER KURT

  • 10% Owner
1,623,405 2018-09-28 0

FRAZIER LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

HERON PATRICK J

FHM LIFE SCIENCES VIII, L.P.

  • 10% Owner
1,939,147 2018-09-28 0

NOVO HOLDINGS A/S

  • 10% Owner
2,181,843 2018-09-28 0

PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.

PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD

  • 10% Owner
1,180,178 2018-09-28 0

STAPLES ANDREW J.

  • Director
0 2018-09-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ALTARAC DAVID - Officer CHIEF MEDICAL OFFICER

2022-01-19 16:00:42 -0500 2022-01-18 A 125,000 a 167,572 direct -5.4348 -14.1304 0.0 1 -14.1304 6

BEHANNA HEATHER - Director

2022-01-19 16:02:48 -0500 2022-01-18 A 27,500 a 49,500 direct -5.4348 -14.1304 0.0 1 -14.1304 6

GUTCH MICHAEL - Officer SEE REMARKS

2022-01-19 16:05:33 -0500 2022-01-18 A 125,000 a 167,572 direct -5.4348 -14.1304 0.0 1 -14.1304 6

MUELLER JOHN PATRICK - Officer CHIEF DEVELOPMENT OFFICER

2022-01-19 16:03:51 -0500 2022-01-18 A 125,000 a 167,092 direct -5.4348 -14.1304 0.0 1 -14.1304 6

MAYER HOWARD - Director

2022-01-19 16:03:10 -0500 2022-01-18 A 27,500 a 49,500 direct -5.4348 -14.1304 0.0 1 -14.1304 6

MEEK DAVID D. - Director

2022-01-19 16:01:51 -0500 2022-01-18 A 27,500 a 49,500 direct -5.4348 -14.1304 0.0 1 -14.1304 6

PERROS MANOUSSOS - Officer SEE REMARKS

2022-01-19 16:04:06 -0500 2022-01-18 A 125,000 a 534,572 direct -5.4348 -14.1304 0.0 1 -14.1304 6

HASTINGS DAVID C - Director

2022-01-19 16:01:18 -0500 2022-01-18 A 27,500 a 49,500 direct -5.4348 -14.1304 0.0 1 -14.1304 6

TRIOLA ANNA DIAZ - Officer CHIEF COMMERCIAL OFFICER

2022-01-19 16:00:23 -0500 2022-01-18 A 125,000 a 125,000 direct -5.4348 -14.1304 0.0 1 -14.1304 6

KEILEY ELIZABETH M - Officer GENERAL COUNSEL

2022-01-19 16:02:16 -0500 2022-01-18 A 125,000 a 167,572 direct -5.4348 -14.1304 0.0 1 -14.1304 6

RONSHEIM MATTHEW - Officer SEE REMARKS

2022-01-19 16:04:31 -0500 2022-01-18 A 125,000 a 167,572 direct -5.4348 -14.1304 0.0 1 -14.1304 6

TOMMASI RUBEN - Officer CHIEF SCIENTIFIC OFFICER

2022-01-19 16:05:59 -0500 2022-01-18 A 125,000 a 189,596 direct -5.4348 -14.1304 0.0 1 -14.1304 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 15:45:04 UTC -1.1251 1.1951 800000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 15:15:03 UTC -1.1251 1.1951 800000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 14:45:03 UTC -1.1181 1.1881 800000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 14:15:03 UTC -1.1181 1.1881 800000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 13:45:03 UTC -1.1181 1.1881 800000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 13:15:03 UTC -1.1181 1.1881 800000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-28 12:45:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 22:15:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 21:45:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 21:15:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 20:45:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 20:15:04 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 19:45:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 19:15:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 18:45:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 18:15:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 17:45:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 17:15:03 UTC -1.1181 1.1881 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 16:45:03 UTC -1.0839 1.1539 750000
ENTASIS THERAPEUTICS HOLDING ETTX 2022-01-27 16:15:03 UTC -1.0839 1.1539 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments